5-4.1 Describe the incidence, morbidity and mortality of endocrinologic emergencies. (C-1)
5-4.2 Identify the risk factors most predisposing to endocrinologic disease. (C-1)
5-4.3 Discuss the anatomy and physiology of organs and structures related to endocrinologic diseases. (C-1)
5-4.4 Review the pathophysiology of endocrinologic emergencies. (C-1)
5-4.5 Discuss the general assessment findings associated with endocrinologic emergencies. (C-1)
5-4.6 Identify the need for rapid intervention of the patient with endocrinologic emergencies. (C-1)
5-4.7 Discuss the management of endocrinologic emergencies. (C-1)
5-4.8 Describe osmotic diuresis and its relationship to diabetes. (C-1)
5-4.9 Describe the pathophysiology of adult onset diabetes mellitus. (C-1)
5-4.10 Describe the pathophysiology of juvenile onset diabetes mellitus. (C-1)
5-4.11 Describe the effects of decreased levels of insulin on the body. (C-1)
5-4.12 Correlate abnormal findings in assessment with clinical significance in the patient with a diabetic emergency. (C-3)
5-4.13 Discuss the management of diabetic emergencies. (C-1)
5-4.14 Integrate the pathophysiological principles and the assessment findings to formulate a field impression and implement a treatment plan for the patient with a diabetic emergency. (C-3)
5-4.15 Differentiate between the pathophysiology of normal glucose metabolism and diabetic glucose metabolism. (C-3)
5-4.16 Describe the mechanism of ketone body formation and its relationship to ketoacidosis. (C-1)
5-4.17 Discuss the physiology of the excretion of potassium and ketone bodies by the kidneys. (C-1)
5-4.18 Describe the relationship of insulin to serum glucose levels. (C-1)
5-4.19 Describe the effects of decreased levels of insulin on the body. (C-1)
5-4.20 Describe the effects of increased serum glucose levels on the body. (C-1)
5-4.21 Discuss the pathophysiology of hypoglycemia. (C-1)
5-4.22 Discuss the utilization of glycogen by the human body as it relates to the pathophysiology of hypoglycemia. (C-3)
5-4.23 Describe the actions of epinephrine as it relates to the pathophysiology of hypoglycemia. (C-3)
5-4.24 Recognize the signs and symptoms of the patient with hypoglycemia. (C-1)
5-4.25 Describe the compensatory mechanisms utilized by the body to promote homeostasis relative to hypoglycemia. (C-1)
5-4.26 Describe the management of a responsive hypoglycemic patient. (C-1)
5-4.27 Correlate abnormal findings in assessment with clinical significance in the patient with hypoglycemia. (C-1)
5-4.28 Discuss the management of the hypoglycemic patient. (C-1)
5-4.29 Integrate the pathophysiological principles and the assessment findings to formulate a field impression and implement a treatment plan for the patient with hypoglycemia. (C-3)
5-4.30 Discuss the pathophysiology of hyperglycemia. (C-1)
5-4.31 Recognize the signs and symptoms of the patient with hyperglycemia. (C-1)
5-4.32 Describe the management of hyperglycemia. (C-1)
5-4.33 Correlate abnormal findings in assessment with clinical significance in the patient with hyperglycemia. (C-3)
5-4.34 Discuss the management of the patient with hyperglycemia. (C-1)
5-4.35 Integrate the pathophysiological principles and the assessment findings to formulate a field impression and implement a treatment plan for the patient with hyperglycemia. (C-3)
5-4.36 Discuss the pathophysiology of nonketotic hyperosmolar coma. (C-1)
5-4.37 Recognize the signs and symptoms of the patient with nonketotic hyperosmolar coma. (C-1)
5-4.38 Describe the management of nonketotic hyperosmolar coma. (C-1)
5-4.39 Correlate abnormal findings in assessment with clinical significance in the patient with nonketotic hyperosmolar coma. (C-3)
5-4.40 Integrate the pathophysiological principles and the assessment findings to formulate a field impression and implement a treatment plan for the patient with nonketotic hyperosmolar coma. (C-3)
5-4.41 Discuss the management of the patient with hyperglycemia. (C-1)
5-4.42 Integrate the pathophysiological principles and the assessment findings to formulate a field impression and implement a treatment plan for the patient with hyperglycemia. (C-3)
5-4.43 Discuss the pathophysiology of diabetic ketoacidosis. (C-1)
5-4.44 Recognize the signs and symptoms of the patient with diabetic ketoacidosis. (C-1)
5-4.45 Describe the management of diabetic ketoacidosis. (C-1)
5-4.46 Correlate abnormal findings in assessment with clinical significance in the patient with diabetic ketoacidosis. (C-3)
5-4.47 Discuss the management of the patient with diabetic ketoacidosis. (C-1)
5-4.48 Integrate the pathophysiological principles and the assessment findings to formulate a field impression and implement a treatment plan for the patient with diabetic ketoacidosis. (C-3)
5-4.49 Discuss the pathophysiology of thyrotoxicosis. (C-1)
5-4.50 Recognize signs and symptoms of the patient with thyrotoxicosis. (C-1)
5-4.51 Describe the management of thyrotoxicosis. (C-1)
5-4.52 Correlate abnormal findings in assessment with clinical significance in the patient with thyrotoxicosis. (C-3)
5-4.53 Discuss the management of the patient with thyrotoxicosis. (C-1)
5-4.54 Integrate the pathophysiological principles and the assessment findings to formulate a field impression and implement a treatment plan for the patient with thyrotoxicosis. (C-3)
5-4.55 Discuss the pathophysiology of myxedema. (C-1)
5-4.56 Recognize signs and symptoms of the patient with myxedema. (C-1)
5-4.57 Describe the management of myxedema. (C-1)
5-4.58 Correlate abnormal findings in assessment with clinical significance in the patient with myxedema. (C-3)
5-4.59 Discuss the management of the patient with myxedema. (C-1)
5-4.60 Integrate the pathophysiological principles and the assessment findings to formulate a field impression and implement a treatment plan for the patient with myxedema. (C-3)
5-4.61 Discuss the pathophysiology of Cushing's syndrome. (C-1)
5-4.62 Recognize signs and symptoms of the patient with Cushing's syndrome. (C-1)
5-4.63 Describe the management of Cushing's syndrome. (C-1)
5-4.64 Correlate abnormal findings in assessment with clinical significance in the patient with Cushing's syndrome. (C-3)
5-4.65 Discuss the management of the patient with Cushing’s syndrome. (C-1)
5-4.66 Integrate the pathophysiological principles and the assessment findings to formulate a field impression and implement a treatment plan for the patient with Cushing's syndrome. (C-3)
5-4.67 Discuss the pathophysiology of adrenal Insufficiency. (C-1)
5-4.68 Recognize signs and symptoms of the patient with adrenal insufficiency. (C-1)
5-4.69 Describe the management of adrenal insufficiency. (C-1)
5-4.70 Correlate abnormal findings in assessment with clinical significance in the patient with adrenal insufficiency. (C-3)
5-4.71 Discuss the management of the patient with adrenal insufficiency. (C-1)
5-4.72 Integrate the pathophysiological principles and the assessment findings to formulate a field impression and implement a treatment plan for the patient with adrenal insufficiency. (C-3)
5-4.73 Integrate the pathophysiological principles to the assessment of a patient with a endocrinological emergency. (C-3)
5-4.74 Differentiate between endocrine emergencies based on assessment and history. (C-3)
5-4.75 Correlate abnormal findings in the assessment with clinical significance in the patient with endocrinologic emergencies. (C-3)
5-4.76 Develop a patient management plan based on field impression in the patient with an endocrinologic emergency. (C-3)